- You can view the full Teva Pharmaceutical Industries Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Analysts are most critical about Teva's plan to cut $5 billion in debt by the end of the year.
For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant
House Democrats start probe into MS drug prices
Jim Cramer is bullish on PayPal, Marriott International, Randgold Resources, and Kirkland Lake.